Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention and treatment of synucleinopathic and amyloidogenic disease

Prevention and treatment of synucleinopathic and amyloidogenic disease

US Patent 8506959 · Granted Aug 13, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline forms of plasma kallikrein inhibitors2025
Crystalline forms of plasma kallikrein inhibitors2022
Processes for preparing plasma kallikrein inhibitors2022
Compositions targeting 3-repeat tau for the treatment of neurodegenerative disor2021
Compositions targeting 3-repeat tau for the treatment of neurodegenerative disor2021
Antibodies to alpha synuclein2018
Use of tau to monitor immunotherapy2016
Prodrugs of inhibitors of plasma kallikrein2015
Hybrid amyloid-beta antibodies2015
Humanized antibodies that recognize beta amyloid peptide2015
Treatment and delay of outset of synucleinopathic and amyloidogenic disease2015
Treatment and delay of outset of synucleinopathic and amyloidogenic disease2015